EP2841456
HUMAN CD30 LIGAND ANTIGEN BINDING PROTEINS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
25.4.2013EP published:
13.6.2018EP application number:
13720714.8
EPO information:
European Patent Register
Max expiry date:
24.4.2033
Title:
HUMAN CD30 LIGAND ANTIGEN BINDING PROTEINS
Timeline
Today
25.4.2013EP application
13.6.2018EP Publication
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880, Bagsværd, DK
Name:
Amgen Inc.Address:
One Amgen Center Drive, 91320-1799, Thousand Oaks, California, US
Inventor
Name:
ANDERSEN, Mette, DahlAddress:
Bagsværd, DK
Name:
DANTZLER, JeffAddress:
Seattle, WA, US
Name:
ARMITAGE, Richard, J.Address:
Bainbridge Island, WA, US
Name:
CLARK, RutilioAddress:
Bainbridge Island, WA, US
Priority
Number:
201261639637 PDate:
27.4.2012Country:
US
Classification
Categories:
C07K 16/28